文献速递中枢神经肿瘤放疗放疗物理与技术

放疗计划CT扫描上的颈部身体成分预测胶质母细胞瘤患者的总生存期

Cervical body composition on radiotherapy planning computed tomography scans predicts overall survival in glioblastoma patients.
PubMed 文献 · Clin Transl Radiat Oncol · 2023-03-27

本研究利用胶质母细胞瘤患者放疗计划头颅CT扫描,半自动量化第一和第二颈椎椎体水平的肌肉与皮下脂肪横截面积,并在324例患者中分析其与总生存期的关联。结果显示颈部身体成分测量与腹部标志物良好相关,低于平均肌肉横截面积或高于平均脂肪横截面积的患者生存期更短,连续肌肉测量在多变量分析中与总生存期独立相关。

要点

  • 颈部身体成分测量与已建立的腹部标志物良好相关(Spearman's rho均大于0.68)。
  • 324例胶质母细胞瘤患者中,低于平均肌肉横截面积或高于平均脂肪横截面积者生存期更短。
  • 多变量分析中,连续颈部肌肉测量与总生存期保持独立关联。

核心结论

  • 这项探索性研究建立了常规头颅放疗计划CT扫描上可获得的颈部身体成分新指标,并证实其与胶质母细胞瘤患者总生存期相关。

研究设计与样本

  • 在开源全身CT队列中验证颈部测量与腹部身体成分的相关性,随后纳入本机构2010年至2020年因新诊断胶质母细胞瘤接受放疗计划的连续患者324例(中位年龄63岁,60.8%男性),在放疗计划CT上量化颈部身体成分,并进行单变量和多变量时间-事件分析,校正年龄、性别、体重指数、合并症、体能状态、手术切除范围、诊断时肿瘤范围及MGMT甲基化。

主要发现

  • 颈部身体成分测量与已建立的腹部标志物良好相关,所有情况下Spearman's rho大于0.68。
  • 研究队列324例胶质母细胞瘤患者中,293例(90.4%)在随访期间死亡,中位生存时间为13个月。
  • 低于平均肌肉横截面积或高于平均脂肪横截面积的患者生存期更短。
  • 多变量分析中,连续颈部肌肉测量与总生存期保持独立关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Glioblastoma (GBM) patients face a strongly unfavorable prognosis despite multimodal therapy regimens. However, individualized mortality prediction remains imprecise. Harnessing routine radiation planning cranial computed tomography (CT) scans, we assessed cervical body composition measures as novel biomarkers for overall survival (OS) in GBM patients. MATERIALS AND METHODS: We performed threshold-based semi-automated quantification of muscle and subcutaneous fat cross-sectional area (CSA) at the levels of the first and second cervical vertebral body. First, we tested this method's validity by correlating cervical measures to established abdominal body composition in an open-source whole-body CT cohort. We then identified consecutive patients undergoing radiation planning for recent GBM diagnosis at our institution from 2010 to 2020 and quantified cervical body composition on radiation planning CT scans. Finally, we performed univariable and multivariable time-to-event analyses, adjusting for age, sex, body mass index, comorbidities, performance status, extent of surgical resection, extent of tumor at diagnosis, and MGMT methylation. RESULTS: Cervical body composition measurements were well-correlated with established abdominal markers (Spearman's rho greater than 0.68 in all cases). Subsequently, we included 324 GBM patients in our study cohort (median age 63 years, 60.8% male). 293 (90.4%) patients died during follow-up. Median survival time was 13 months. Patients with below-average muscle CSA or above-average fat CSA demonstrated shorter survival. In multivariable analyses, continuous cervical muscle measurements remained independently associated with OS. CONCLUSION: This exploratory study establishes novel cervical body composition measures routinely available on cranial radiation planning CT scans and confirms their association with OS in patients diagnosed with GBM.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Troschel FM, Troschel BO, Kloss M, et al. Cervical body composition on radiotherapy planning computed tomography scans predicts overall survival in glioblastoma patients. Clin Transl Radiat Oncol. 2023. PMID: 37008514. doi:10.1016/j.ctro.2023.100621

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。